1. Home
  2. CACC vs KRYS Comparison

CACC vs KRYS Comparison

Compare CACC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACC
  • KRYS
  • Stock Information
  • Founded
  • CACC 1972
  • KRYS 2015
  • Country
  • CACC United States
  • KRYS United States
  • Employees
  • CACC N/A
  • KRYS N/A
  • Industry
  • CACC Finance: Consumer Services
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CACC Finance
  • KRYS Health Care
  • Exchange
  • CACC Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • CACC 5.7B
  • KRYS 4.9B
  • IPO Year
  • CACC 1992
  • KRYS 2017
  • Fundamental
  • Price
  • CACC $473.10
  • KRYS $190.40
  • Analyst Decision
  • CACC Strong Sell
  • KRYS Strong Buy
  • Analyst Count
  • CACC 1
  • KRYS 7
  • Target Price
  • CACC $380.00
  • KRYS $206.00
  • AVG Volume (30 Days)
  • CACC 89.0K
  • KRYS 276.6K
  • Earning Date
  • CACC 10-30-2024
  • KRYS 11-04-2024
  • Dividend Yield
  • CACC N/A
  • KRYS N/A
  • EPS Growth
  • CACC N/A
  • KRYS N/A
  • EPS
  • CACC 15.07
  • KRYS 1.77
  • Revenue
  • CACC $846,100,000.00
  • KRYS $241,519,000.00
  • Revenue This Year
  • CACC N/A
  • KRYS $485.65
  • Revenue Next Year
  • CACC $10.08
  • KRYS $58.64
  • P/E Ratio
  • CACC $31.12
  • KRYS $107.38
  • Revenue Growth
  • CACC N/A
  • KRYS 2722.80
  • 52 Week Low
  • CACC $409.22
  • KRYS $99.00
  • 52 Week High
  • CACC $616.66
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • CACC 62.21
  • KRYS 58.73
  • Support Level
  • CACC $437.64
  • KRYS $168.88
  • Resistance Level
  • CACC $450.73
  • KRYS $207.84
  • Average True Range (ATR)
  • CACC 13.42
  • KRYS 9.60
  • MACD
  • CACC 2.76
  • KRYS 0.43
  • Stochastic Oscillator
  • CACC 98.35
  • KRYS 55.24

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: